The report surveyed 100 CFOs from organizations with revenues ranging from $250 million to $3 billion or more. The CFOs represented an even split of hospitals/health systems, academic medical centers, physician groups, outpatient/ASC, and long-term/post-acute or homecare organizations.
The survey was conducted in November 2024 by Rabin Roberts Research Company, an independent marketing research firm, using Slice MR’s panel of executives.
Five things to know:
1. Seventy-two percent of CFOs expect revenue to increase in 2025, and 48% expect profitability to increase. Eighty-four percent of respondents reported increased revenue in 2024, and 43% reported increased profitability.
2. All respondents said they plan to invest in artificial intelligence in 2025, and 84% expect to invest as much or more than they did in 2024. Of those surveyed, 81% said AI is a “moderate or significant concern” for their leadership team. Fifty-seven percent said they plan to increase their involvement in strategic conversations around digital transformation and AI in 2025.
3. Forty-five percent of CFOs said they plan to increase cybersecurity spending in 2025, and 37% said they feel “very prepared” to handle a ransomware incident.
4. Fifty-seven percent said they plan to pursue a transaction or partnership in 2025, with 41% planning an enterprise sale to a strategic buyer/competitor; 32% planning a restructuring or reorganization; 28% planning a joint venture or alliance; and 27% planning a carve-out or divestiture.
5. Thirty-seven percent said they plan to increase hiring in 2025, up from 25% in 2024.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
